Twinstrand Biosciences Announces $50 Million Series B To Expand The Adoption Of Its Duplex Sequencing Technology In Applications Requiring The Highest Sensitivity And Accuracy
Amount Raised
$50 Million
Round Type
Series B
SeattleInformation TechnologyBiotechnologyDescription
TwinStrand Biosciences, the pioneer and developer of Duplex Sequencing, an ultra-high accuracy technology for revealing exceptionally low-frequency genetic variants, today announced that it has closed a $50 million Series B financing led by Section 32, with participation from new investors Soleus Capital, Janus Henderson Investors, and existing investors Madrona Venture Group, Ridgeback Capital, and Alexandria Venture Investments, among others. As part of the financing, Michael Pellini, MD, Partner at Section 32, will join the TwinStrand Board of Directors.
Quick answer
TwinStrand Biosciences, Inc. raised $50 Million in a Series B round, dated May 6, 2021. TwinStrand Biosciences, Inc. is based in Seattle, Washington, United States.
- How much did TwinStrand Biosciences, Inc. raise?
- TwinStrand Biosciences, Inc. raised $50 Million in a Series B round on May 6, 2021.
- What does TwinStrand Biosciences, Inc. do?
- We are a vibrant young company committed to science first.
- Where is TwinStrand Biosciences, Inc. based and how big is it?
- TwinStrand Biosciences, Inc. is based in Seattle, Washington, United States.
- Who are the decision-makers at TwinStrand Biosciences, Inc?
- Fundz holds 1 contact at TwinStrand Biosciences, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as TwinStrand Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Nuevocor raised $24M (Series A) on June 18, 2021.
- DarioHealth raised $24M on June 17, 2021.
- Pinteon Therapeutics, Inc. raised an undisclosed amount (Grant) on June 17, 2021.
- OncoNano Medicine raised $50M (Series B) on June 17, 2021.
- Labviva raised $8M on June 17, 2021.
- SeLux Diagnostics, Inc. raised $2.5M (Seed) on June 17, 2021.
Who to call at TwinStrand Biosciences, Inc., and when
A new round usually means TwinStrand Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TwinStrand Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TwinStrand Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TwinStrand Biosciences, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TwinStrand Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTwinStrand Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.